PRIVIA HEALTH GROUP INC (PRVA) Stock Earnings Estimates

USA • Nasdaq • NASDAQ:PRVA • US74276R1023

23.22 USD
+0.35 (+1.53%)
At close: Jan 30, 2026
23.22 USD
0 (0%)
After Hours: 1/30/2026, 8:13:55 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027 2028 2029 2030 2031
Revenue
YoY % growth
PRVA revenue by date.PRVA revenue by date.
1.357B
40.42%
1.658B
22.19%
1.736B
4.74%
2.139B
23.19%
2.433B
13.74%
2.631B
8.14%
3.03B
15.17%
3.386B
11.75%
3.784B
11.75%
3.453B
-8.75%
EBITDA
YoY % growth
PRVA ebitda by date.PRVA ebitda by date.
-14.53M
93.24%
27.182M
287.08%
24.25M
-10.79%
122.07M
403.38%
145.22M
18.96%
170.78M
17.60%
192.17M
12.52%
216.65M
12.74%
242.76M
12.05%
270.5M
11.43%
EBIT
YoY % growth
PRVA ebit by date.PRVA ebit by date.
-19.1M
91.21%
20.649M
208.11%
16.982M
-17.76%
26.342M
55.12%
51.926M
97.12%
90.954M
75.16%
99.348M
9.23%
122.2M
23.00%
146.68M
20.03%
172.69M
17.73%
Operating Margin
PRVA operating margin by date.PRVA operating margin by date.
-1.41%1.25%0.98%1.23%2.13%3.46%3.28%3.61%3.88%5.00%
EPS
YoY % growth
PRVA eps by date.PRVA eps by date.
0.13
107.14%
0.19
46.15%
0.11
-42.11%
0.13
22.00%
0.32
138.76%
0.53
65.85%
N/AN/AN/AN/A

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26 Q1 / 27 Q2 / 27 Q3 / 27 Q4 / 27
EPS
Q2Q % growth
0.04
19.00%
0.07
130.18%
0.08
276.48%
0.10
96.02%
0.08
131.94%
0.09
28.02%
0.10
30.95%
0.11
11.01%
0.14
64.24%
Revenue
Q2Q % growth
599.59M
-24.34%
599.61M
-24.92%
883.02M
2.33%
921.89M
-1.97%
900.86M
50.25%
1.019B
69.94%
1.049B
18.80%
1.083B
17.48%
1.11B
23.22%
EBITDA
Q2Q % growth
26.439M
111.24%
33.225M
366.71%
35.472M
353.61%
40.23M
85.79%
36.892M
39.54%
37.586M
13.13%
39.437M
11.18%
42.568M
5.81%
47.437M
28.58%
EBIT
Q2Q % growth
4.736M
-9.76%
10.711M
105.27%
12.194M
265.53%
12.909M
-10.37%
15.042M
217.61%
12.828M
19.76%
14.552M
19.34%
16.725M
29.56%
21.77M
44.73%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
0.05
66.67%
0.050.00-8.97%
Q2 2025
Q2Q % growth
0.02
-33.33%
0.05-0.03-60.96%
Q1 2025
Q2Q % growth
0.03
50.00%
0.05-0.02-37.83%
Q4 2024
Q2Q % growth
0.03
50.00%
0.05-0.02-40.79%
Q3 2024
Q2Q % growth
0.03
-40.00%
0.05-0.02-38.73%
Q2 2024
Q2Q % growth
0.03
-50.00%
0.05-0.02-36.27%
Q1 2024
Q2Q % growth
0.02
-66.67%
0.05-0.03-58.84%
Q4 2023
Q2Q % growth
0.02
-85.71%
0.04-0.02-53.66%
Q3 2023
Q2Q % growth
0.05
400.00%
0.050.00-1.96%
Q2 2023
Q2Q % growth
0.06
-57.14%
0.060.005.32%
Q1 2023
Q2Q % growth
0.06
137.50%
0.020.04222.32%
Q4 2022
Q2Q % growth
0.14
227.27%
-0.030.17596.58%
Q3 2022
Q2Q % growth
0.01
111.11%
0.000.01105.10%
Q2 2022
Q2Q % growth
0.14
108.33%
-0.030.17625.68%
Q1 2022
Q2Q % growth
-0.16
-366.67%
-0.04-0.12-331.77%
Q4 2021
Q2Q % growth
-0.11 -0.140.0319.35%
Q3 2021
Q2Q % growth
-0.09 -0.110.0218.52%
Q2 2021
Q2Q % growth
-1.68 -1.720.042.54%
Q1 2021
Q2Q % growth
0.06 0.040.0234.21%
PRVA Yearly EPS VS EstimatesPRVA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
940.4M
27.10%
797.58M142.82M17.91%
Q2 2025
Q2Q % growth
862.9M
18.53%
816.11M46.79M5.73%
Q1 2025
Q2Q % growth
798.6M
12.84%
792.62M5.98M0.75%
Q4 2024
Q2Q % growth
792.5M
4.74%
734.37M58.13M7.92%
Q3 2024
Q2Q % growth
739.9M
2.27%
729.08M10.82M1.48%
Q2 2024
Q2Q % growth
728M
4.00%
720.57M7.43M1.03%
Q1 2024
Q2Q % growth
707.7M
7.41%
667.44M40.26M6.03%
Q4 2023
Q2Q % growth
756.6M
107.63%
739.91M16.69M2.26%
Q3 2023
Q2Q % growth
723.5M
110.99%
716.51M6.99M0.98%
Q2 2023
Q2Q % growth
700M
108.64%
699.7M300K0.04%
Q1 2023
Q2Q % growth
658.9M
109.97%
666.03M-7.13M-1.07%
Q4 2022
Q2Q % growth
364.4M
32.36%
598.88M-234.48M-39.15%
Q3 2022
Q2Q % growth
342.9M
36.34%
541.28M-198.38M-36.65%
Q2 2022
Q2Q % growth
335.5M
48.58%
533.59M-198.09M-37.12%
Q1 2022
Q2Q % growth
313.8M
46.91%
521.87M-208.07M-39.87%
Q4 2021
Q2Q % growth
275.3M
28.83%
426.82M-151.52M-35.50%
Q3 2021
Q2Q % growth
251.5M
21.38%
237.27M14.23M6.00%
Q2 2021
Q2Q % growth
225.8M
23.19%
219.32M6.48M2.95%
Q1 2021
Q2Q % growth
213.6M
0.33%
201.27M12.33M6.13%
PRVA Yearly Revenue VS EstimatesPRVA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% -44.24% 0% -19.32%
Revenue-25.47% -18.41% -39.9% -37.44%